Skip to main content
. 2018 Feb 14;26(4):1082–1092. doi: 10.1016/j.ymthe.2018.02.008

Figure 2.

Figure 2

In Vivo Validation of shRNA Targeting Dnm2 following Intramuscular Injection

(A) Representative western blot of 7-week-old WT or Mtm1KO TAs injected with either AAV-shRNA ctrl or AAV-shDnm2 (B, C, F, I, or J). (B) DNM2 densitometries were quantified and standardized to the loading control GAPDH (n = 5–7 mice/group). ***p < 0.01 versus WT muscles treated with AAV-shRNA ctrl (ANOVA test).